Home > Events > Valuation of Intangibles, May 2011 > Valuation of Intangibles: Speakers

Valuation of Intangibles: Speakers

Training Week #2 - Valuation of Intangibles
Valuation of licensing opportunities and early stage companies
UATEC, Aveiro - 10-11 May 2011
Home | Program | Speakers | Registration | Venue | Accommodations | Resources | Photos

Co-organized by UTEN Portugal and the Carnegie Mellon Portugal Program

Tara BranstadTara Branstad
Associate Director
Center for Technology Transfer and Enterprise Creation (CTTEC), CMU

Tara works primarily with CMU faculty in Robotics, Biomedical Engineering, Computational Biology, Computer Science, Cylab (computer security), and the Tepper School (business). Tara has worked with a variety of licensing models, including traditional commercial, open source, and new company creation. In her capacity as Associate Director of CTTEC, Tara is responsible for overseeing our Enterprise Creation (start-up) activities and managing our Gap Fund Program. She also assists the Director with administrative and finance duties.

Tara came to CMU in October 2005. She began her professional career in technology transfer at the University of Pittsburgh’s Office of Technology Management. She then worked at Innovation Works, a seed stage funding and technology-based economic development organization, and as an independent consultant. Tara is married to a serial entrepreneur and has two young children. She received her BA in Biology from the University of Virginia and her MBA/MHA in marketing and health policy and administration from the University of Pittsburgh.

Barbara CarryerBarbara Carryer
Adjunct Professor, Entrepreneurship
Embedded Entrepreneur, Project Olympus
Innovation Advisor, Institute for Social Innovation
Carnegie Mellon University

Babs Carryer is adjunct professor of entrepreneurship at the Heinz College and the Don Jones Center for Entrepreneurship in Tepper School of Business. She is the embedded entrepreneur for Project Olympus, which was founded within CMU’s School of Computer Science to stimulate entrepreneurship and the commercialization of new technologies.

Babs teaches new technology commercialization through the University of Pittsburgh’s Offices of Enterprise Development and Technology Management.

Babs is also is President of Carryer Consulting, which provides strategic marketing and business planning services to technology companies and organizations in the software and life sciences sectors.

Babs co-founded LaunchCyte, a development company that creates, seeds, and harvests life sciences innovations from leading research universities across the U.S. In 2009, one LaunchCyte company announced a strategic partnership with Philips, including a five figure investment, to develop a diagnostic device for sepsis; in 2010, another LaunchCyte company announced a $345M deal with Biogen to develop and commercialize a new drug for the treatment of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.

Babs is past director of deal flow for BlueTree Allied Angels, a regional angel investment group with $15 million under management.

In the fall of 2008, Babs was the Bishoff entrepreneur-in-residence at Penn State University.

Raymond F. VennareRaymond F. Vennare
President, CEO and Co-Founder of ThermalTherapeutic Systems

An accomplished senior executive and serial entrepreneur with more than fifteen years of hands-on experience building and growing information technology, informatics and biotechnology companies across diverse markets, Raymond is the former Chief Executive Officer of ImmunoSite, Inc., Senior Vice President and Chief Information Officer of TissueInformatics, Inc. and President of VS/Interactive, LLC. Collectively these companies have raised in excess of $25 million from private, public, corporate and professional investment sources. A frequent speaker on issues related to leadership, business ethics, strategic thinking and entrepreneurship, Raymond’s expertise includes executive management, corporate governance and the commercialization of emerging and innovative new technologies.